Axon seminar Cell-Based Therapies, Amsterdam, 18 April

I hope you won’t mind me doing a little bit of marketing for the non-devices activities of my firm. Axon Lawyers organises a seminar on cell-based therapies on 18 April in Amsterdam, which will be very interesting for companies thinking about or already underway with such products in the EU as it will be specifically focused on the difficult questions and practical problems that a company faces in bringing this type of product to the market. We have secured some veritable opinion leaders in the field and attendance is completely free, but please RSVP so we won’t have to disappoint people. If you feel this seminar would benefit anyone, whether in your company or not, please feel free to forward the invitation. If you would like to receive the seminar presentations and handouts, we will be happy to send them to you if you send us an email at the RSVP email address.


Navigate through our knowledgebase

Related articles

Article

New sort of applicable economic operators regulation: the Market Surveillance Regulation

Attentive attendees of my presentations will have remarked in my presentations about economic operators that essential parts of the general Goods Package were being amended and that this may affect companies in…

Read more

Article

Transparency vs. Confidentiality: EFSA’s new role as from March 2021

Last month, the European Council formally adopted the new Regulation on the transparency of the EU risk assessment in the food chain, which will be applicable as of 26 March 2021. As is in the name, the new provisions aim at increased transparency of EU risk assessment, which for a large deal means strengthening the […]

Article

€ 500 per data subject – a quantification of why GDPR matters

Clients often ask me why they should invest in General Data Protection Regulation (GDPR) compliance so much. For medical devices and medicines regulatory compliance, they get it to an extent. Non-compliant devices…

Read more